文献速递细菌感染、耐药与抗菌药物

多黏菌素B联合13种抗生素对产碳青霉烯酶肺炎克雷伯菌的体外活性评估

Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
PubMed 文献 · Clin Microbiol Infect · 2020-03-26

该研究用5株产KPC-2、KPC-3、NDM-1、OXA-48和VIM-1碳青霉烯酶的临床肺炎克雷伯菌,通过24小时延时显微镜筛选多黏菌素B联合13种抗生素的相互作用,阳性组合再用时间杀菌实验验证。结果显示多黏菌素B联合米诺环素对所有菌株均增强活性,联合利福平或磷霉素对4/5菌株有阳性作用,时间杀菌实验中21/23组合呈相加或协同,但因再生仅13个组合在24小时协同。

要点

  • 多黏菌素B联合米诺环素对全部5株受试菌均显示增强活性。
  • 联合利福平或磷霉素对4/5菌株显示阳性相互作用。
  • 24小时时间杀菌实验仅13/23组合维持协同,部分因细菌再生。

核心结论

  • 多黏菌素B联合米诺环素、利福平或磷霉素可能具有潜在临床价值。

研究设计与样本

  • 体外研究,使用5株多重耐药产碳青霉烯酶肺炎克雷伯菌临床分离株。
  • 先以24小时自动延时显微镜筛选多黏菌素B联合13种抗生素,阳性组合再行静态时间杀菌实验。

主要发现

  • 所有菌株全基因组测序检出≥9个耐药基因。
  • 初筛中多黏菌素B联合米诺环素对所有菌株活性增强。
  • 多黏菌素B联合利福平或磷霉素对4/5菌株显示阳性相互作用。
  • 时间杀菌实验中21/23组合呈相加或协同(分别较最强单药降低1-2 log10或≥2 log10 CFU/mL)。
  • 因再生仅13个组合在24小时协同;联合米诺环素或利福平对4株菌24小时分别降低1.93-3.97和2.55-5.91 log10 CFU/mL。

临床怎么用

  • 对产碳青霉烯酶肺炎克雷伯菌,多黏菌素B联合米诺环素、利福平或磷霉素可作为潜在联合方案参考。
  • 延时显微镜可用于联合方案的初步筛选,但结果与时间杀菌实验存在差异。

局限性

  • 仅5株临床分离株,样本量小。
  • 延时显微镜与时间杀菌实验结果存在差异。
  • 因再生部分组合24小时未能维持协同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to explore the interactions of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae. METHODS: Five clinical isolates of multidrug-resistant K. pneumoniae producing KPC-2, KPC-3, NDM-1, OXA-48 and VIM-1 carbapenemases were used. Polymyxin B was tested alone and in combination with amikacin, aztreonam, cefepime, chloramphenicol, ciprofloxacin, fosfomycin, linezolid, meropenem, minocycline, rifampicin, temocillin, thiamphenicol and trimethoprim. Inhibition of growth during antibiotic exposure was evaluated in 24-hr automated time-lapse microscopy experiments. Combinations that showed positive interactions were subsequently evaluated in static time-kill experiments. RESULTS: All strains carried multiple (≥9) resistance genes as determined by whole-genome sequencing. In the initial screening the combination of polymyxin B and minocycline was most active with enhanced activity compared with the single antibiotics detected against all strains. Positive interactions were also observed with polymyxin B in combination with rifampicin and fosfomycin against four of five strains and less frequently with other antibiotics. Time-kill experiments demonstrated an additive or synergistic activity (1-2 log10 or ≥2 log10 CFU/mL reduction, respectively, compared with the most potent single antibiotic) with 21 of 23 tested combinations. However, because of regrowth, only 13 combinations were synergistic at 24 hr. Combinations with minocycline or rifampicin were most active, each showing synergy and bacteriostatic or bactericidal effects resulting in 1.93-3.97 and 2.55-5.91 log10 CFU/mL reductions, respectively, after 24 hr against four strains. DISCUSSION: Polymyxin B in combination with minocycline, rifampicin or fosfomycin could be of potential clinical interest. Time-lapse microscopy showed some discrepancy in results compared with the time-kill data but was useful for screening purposes.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Wistrand-Yuen P, Olsson A, Skarp KP, et al. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments. Clin Microbiol Infect. 2020. PMID: 32224200. doi:10.1016/j.cmi.2020.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。